We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

342 hedge funds and large institutions have $7.01B invested in PRA Health Sciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 140 increasing their positions, 105 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 21

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

33% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 105

16% more capital invested

Capital invested by funds: $6.04B → $7.01B (+$974M)

14% more funds holding

Funds holding: 300342 (+42)

53% less call options, than puts

Call options by funds: $6.04M | Put options by funds: $12.9M

Holders
342
Holders Change
+42
Holders Change %
+14%
% of All Funds
7.82%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.16%
New
65
Increased
140
Reduced
105
Closed
21
Calls
$6.04M
Puts
$12.9M
Net Calls
-$6.85M
Net Calls Change
-$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
SGA
226
Strategic Global Advisors
California
$660K
RG
227
Renaissance Group
Kentucky
$656K +$17.2K +165 +3%
LPL Financial
228
LPL Financial
California
$650K +$158K +1,520 +35%
WG
229
Winton Group
United Kingdom
$647K +$3.44K +33 +0.6%
MCIM
230
Meadow Creek Investment Management
Georgia
$640K +$605K +5,808 New
GH
231
GAM Holding
Switzerland
$627K +$117K +1,121 +25%
FL
232
Fort LP
Maryland
$627K +$593K +5,694 New
LCG
233
Lisanti Capital Growth
New York
$612K +$578K +5,555 New
WSCM
234
Wellington Shields Capital Management
New York
$551K +$521K +5,000 New
TRCT
235
Tower Research Capital (TRC)
New York
$550K +$478K +4,588 +1,133%
JIP
236
Jaffetilchin Investment Partners
Florida
$545K -$9.16K -88 -2%
BNP Paribas Financial Markets
237
BNP Paribas Financial Markets
France
$524K +$88.3K +848 +22%
SO
238
STRS Ohio
Ohio
$504K +$59.2K +569 +14%
BNP Paribas Asset Management
239
BNP Paribas Asset Management
France
$500K -$269K -2,585 -36%
VI
240
Versor Investments
New York
$496K -$167K -1,600 -26%
FM
241
Forward Management
California
$494K -$107K -1,030 -19%
CM
242
Castleark Management
Illinois
$472K +$236K +2,270 +113%
FCM
243
Flinton Capital Management
Pennsylvania
$465K +$440K +4,224 New
PIA
244
Piedmont Investment Advisors
North Carolina
$455K +$430K +4,127 New
ECM
245
ETrade Capital Management
Virginia
$452K +$141K +1,355 +49%
BTS
246
BB&T Securities
Virginia
$451K +$171K +1,643 +67%
ACM
247
AlphaStar Capital Management
North Carolina
$448K +$18.7K +180 +5%
LIA
248
LS Investment Advisors
Michigan
$446K +$81.6K +784 +24%
FRM
249
Fox Run Management
Connecticut
$441K +$193K +1,850 +86%
MF
250
Magnetar Financial
Illinois
$430K -$3.01M -28,953 -88%

PRAH Hedge Fund Activity: Q3 2018 in Review

342 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2018, worth a combined $7.01B — up 16% from $6.04B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new PRAH positions and 21 closed out — a net gain of 44 holders — while 140 added to existing stakes and 105 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $115M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $677M.

  • 342 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2018, up from 300 in Q2 2018.
  • Funds reported $7.01B of PRA Health Sciences, Inc. stock for Q3 2018, up 16% quarter-over-quarter.
  • 65 funds opened new PRA Health Sciences, Inc. positions in Q3 2018 and 21 closed out, a net change of +44 holders.
  • The largest PRA Health Sciences, Inc. buyer in Q3 2018 was Wellington Management Group, an estimated $115M added.
  • The largest PRA Health Sciences, Inc. seller in Q3 2018 was Kohlberg Kravis Roberts & Co, an estimated $677M sold.

Based on aggregated 13F filings for Q3 2018.